Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations
Gigante, D.; Teodori, S.; Crispo, M.
Fortschritte der Medizin 101(13): 613-618
1983
ISSN/ISBN: 0015-8178 PMID: 6852728 Document Number: 216300
Document emailed within 1 workday
Related Documents
Waskönig, F.W.; Meyer, W. 1973: The basal therapy of rheumatoid arthritis with d-penicillamine Münchener Medizinische Wochenschrift 115(45): 2047-2050Gawryluk, D.; Załeska, M.; Langfort, R.; Oniszh, K.; Kowalski, J.; Wiatr, E.; Załeska, J.; Rowińska-Zakrzewska, E. 1998: Changes in the respiratory system of patients with rheumatoid arthritis--personal observations Pneumonologia i Alergologia Polska 66(1-2): 54-65
Miyamoto, S.; Inoue, T. 1992: Gold compounds and D-penicillamine for therapy of rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 50(3): 515-520
Huskisson, E.C. 1981: The side effects of penicillamine therapy in rheumatoid arthritis Journal of Rheumatology. Suppl 7: 146-148
Keitel, W.; Keitel, R. 1999: Basic therapy of rheumatoid arthritis. 2: Selection, long-term and combination therapy MMW Fortschritte der Medizin 141(37): 42-44
Gräfenstein, K. 1988: Basic drug therapy of rheumatoid arthritis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 43(1): 18-20
Frizen, B.N.; Dormidontov, E.N. 1992: The efficacy of basic therapy in rheumatoid arthritis with methotrexate Terapevticheskii Arkhiv 64(5): 34-36
Goriachev, D.V.; Erdes, S.F. 2004: Markov model of decision making for basic therapy of rheumatoid arthritis: oder of monotherapy and expenses for drug therapy Terapevticheskii Arkhiv 76(5): 35-39
2000: Rheumatoid arthritis: a new basic therapy. Proliferating T-cells controlled MMW Fortschritte der Medizin 142(17): 51
Tsitlanadze, V.G.; Dzidziguri, L.M.; Tkemaladze, L.M.; Kartvelishvili, E.I.; Shakulashvili, N.A. 1981: Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis Terapevticheskii Arkhiv 53(7): 72-74
Krel', A.A.; Semenova, O.I.; Kanevskaia, M.Z. 1992: The possibilities for a modifying influence of basic therapy on the long-term course of rheumatoid arthritis Terapevticheskii Arkhiv 64(5): 41-47
Seideman, P.; Lindström, B. 1989: Pharmacokinetic interactions of penicillamine in rheumatoid arthritis Journal of Rheumatology 16(4): 473-474
Brenner, S.; Caspi, D.; Tchetchik, R.; Krakowski, A.; Yaron, M. 1983: Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis Harefuah 104(3): 94-96
Christoph, R.; Genth, E.; Grussendorf, E.I.; Hartl, P.W. 1978: Pemphigus syndrome in D-penicillamine treated rheumatoid arthritis Die Medizinische Welt 29(45): 1761-1763
Gordon, R.A.; Burnside, J.W. 1977: D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis Annals of Internal Medicine 87(5): 578-579
Matthey, F.; Perrett, D.; Greenwood, R.N.; Baker, L.R. 1986: The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis Clinical Nephrology 25(5): 268-271
Siame, J.L.; Cocheteux, P.; Delcambre, B. 1981: Severe bronchiolitis in rheumatoid arthritis treated with D-penicillamine Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(7-9): 605-606
Ongerboer de Visser, B.W.; van Soesbergen, R.M. 1978: Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis Nederlands Tijdschrift Voor Geneeskunde 122(52): 2055-2058
Partsch, G.; Tausch, G.; Neuwirth, E.; Neumüller, J. 1983: The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis Zeitschrift für Rheumatologie 42(3): 126-129
Huskisson, E.C.; Berry, H. 1974: Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold Postgraduate Medical Journal 50(Suppl 2): 59-61